3-Oxo-5-[[2-(trifluoromethyl)phenyl]amino]-2,3-dihydroisothiazole-4-carbonitrile is an inhibitor of bone morphogenetic protein 2 (BMP2) with an IC50 of 2.2 μM; 3-Hydroxy-4-carboxyalkylamidino-5-arylamino-isothiazoles are inhibitors of mitogen-activated protein kinase 1 (MEK1) and exhibit anti-inflammatory and neuroprotective activities in the EAE mouse model.